Search database
LIST OPTIONS
Filter
152
Filtered Results: 152
Text search: EMA European Medicines Agency
Featured
Language
Document type
No document type
55
Guidelines
40
Studies & Reports
25
Fact sheets
21
Manuals
6
Situation Updates
2
Strategic & Response Plan
2
Training Material
1
Countries / Regions
Germany
7
Western and Central Europe
5
West and Central Africa
3
Brazil
2
Colombia
2
East and Southern Africa
2
Africa
2
Eastern Europe
2
Guinea
1
Sierra Leone
1
Liberia
1
Congo, Democratic Republic of
1
Ethiopia
1
Uganda
1
Philippines
1
India
1
Nepal
1
Zambia
1
Kenya
1
Cambodia
1
Thailand
1
Indonesia
1
Bangladesh
1
Argentina
1
Peru
1
Ukraine
1
Ecuador
1
Chile
1
Latin America and the Carribbean
1
Paraguay
1
Venezuela
1
Tajikistan
1
Russia
1
Denmark
1
Authors & Publishers
World Health Organization WHO
33
World Health Organization
8
European Medicines Agency EMA
6
Robert-Koch-Institut RKI
5
et al.
4
World Health Organisation (WHO)
4
World Health Organization (WHO)
4
Africa CDC Centres for Disease Control and Prevention
3
African Union
3
European Centre for Disease Prevention and Control ECDC
3
ReAct
3
UNITAID
3
AIDSinfo
2
European Monitoring Centre for Drugs and Drug Addiction
2
Food and Agriculture Organization of the United Nations FAO
2
International Pharmaceutical Federation (FIP)
2
Robert-Koch-Institut
2
Wellcome Trust
2
WHO Europe
2
World Health Organization WHO, Regional Office of Europe
2
A. Benzacar
1
A.Hill, T. Swan and K.Timmermans
1
Access Campaign, Médecins sans Frontières
1
Access to Medicine Foundation
1
ACCSI
1
Africa CDC
1
AMR Industry Alliance
1
and P. Reijer
1
Appleton, R.E. & Cross, J.H.
1
Belkum, A.van, T. T. Bachmann, G. Lüdke, et al.
1
BMA
1
Bortone, B.
1
Boston Consulting Group
1
Bracho C., Martinez C. et al.
1
BUKO Pharma-Kampagne
1
C. Clift
1
Centre for Antibiotic Resistance Research (CARe), University of Gothenburg
1
Cerda A. A., Garcia L. Y.
1
CIDRAP
1
Corrado Barbui, Tarun Dua, Kavitha Kolappa et al.
1
E. Ross
1
EMA European Medicines Agency
1
Erin Berry-Bibee, Melissa Chen, Kathryn Curtis et al.
1
Ethiopian Food and Drug Authority
1
European Centers for Disease Control and Prevention ECDC
1
European Centre for Disease Prevention and Control
1
European Centre for Disease Prevention and Control (ECDC)
1
European Centre for Disease Prevention and Control (ECDC), European Food Safety Authority (EFSA) andEuropean Medicines Agency (EMA)
1
European Commission, Government of Luxembourg
1
European Medicine Agency
1
European Medicines Agency
1
European Public Health Alliance
1
European specialist nurse organisation (ESN)
1
European Union
1
European Union EU
1
Flying Publisher
1
Flying Publisher, Boehringer Ingelheim
1
Fuchs A., J. Bielickia, S. Mathur, et.al.
1
Harding-Zentrum für Risikokompetenz
1
HIV i-Base
1
HIV i-BASE/TREATMENT ACTION GROUP
1
Hooiveld, M.
1
i-base
1
Indian Consensus of Medical Research
1
Indonesian Heart Association
1
International League Against Epilepsy (UK Chapter) and Epilepsy Society
1
JSI Research & Training Institute, Inc., and Management Sciences for Health
1
K.L Tang, N.P Caffrey, D.B Nóbrega, et al.
1
Ledingham, K.
1
Marks, S. et al.
1
Mauder, S.
1
Médecins Sans Frontières
1
Médecins Sans Frontières (MSF)
1
Médecins sans Frontières MSF
1
Ministerio da Saude, Brasilia
1
Ministerio de Salud Argentina
1
Ministerio de Salud Pública de Ecuador
1
Ministerio de Salud y Protección Social Bogotá, Colombia
1
Ministerio de Salud, Colombia
1
Ministerio de Salud, Peru
1
Ministry of Health, Kenya
1
Ministry of Health, Zambia
1
MSF Access Campaign
1
MSF Médecins sans Frontières
1
N. Gebreselassie , C. Lienhardt, L. Anderson et al.
1
National Drug Authority, Uganda
1
Nwokike J., Ludeman E., Thumm M.
1
OECD
1
OPAS
1
Organisation Mondiale de la Santé OMS
1
Organización Mundial de la Salud OMS
1
Organização Mundial da Saúde (OMS)
1
P. Clayden
1
Pan American Health Organisation PAHO
1
Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children
1
Patricia M.C. Huijbers, Carl-Fredrik Flach, D.G. Joakim Larsson
1
PLoS One
1
Polly Clayden, Simon Collins, Mike Frick, et al.
1
Rahman-Shepherd, A.
1
ReAct Action on Antibiotic Resistance
1
Reliefweb OCHA Services
1
RKI
1
Robert-Koch-Instiut RKI
1
Royal Pharmaceutical Society, etal.
1
Ruff, P.
1
S. Groth, G. Forte et al.
1
Sana-Al-Sukhun, C. Blanchard, et al.
1
Segvia, E. V. L. et al.
1
Sentinel Project
1
Sociedad Paraguaya de Pediatria
1
Stefan Mauss, et al.
1
Stefan Mauss, Thomas Berg, Jürgen Rockstroh et al.
1
Stop TB Partnership
1
The Chatham House
1
UNAIDS
1
Unicef
1
USAID, SIAPS
1
Van Deursen, B.
1
Velazquez Berumen, A.
1
World Health Organization WHO
1
World Health Organization (Europe)
1
World Health Organization and Calouste Gulbenkian Foundation
1
World Health Organization Europe
1
World Health Organization WHO, et al.
1
World Health Organization WHO, Food and Agriculture Organization of the United Nations FAO
1
World Health Organization WHO, Stop TB
1
Yuniadi, Y., A.E. Tondas, D.A. Hanafy, et al.,
1
Всемирная организация здравоохранения (Европейское)
1
Г-жа M. Mansfeld
1
Г-н Z. T. Gavry
1
Д-р M. Dara
1
министерство здравоохранения и социальной защиты населения республики таджикистан, US Aid, Challenge TB
1
Юсуфи С. Д., Раджабов А. С., Сангинов А. Б. et al.
1
Publication Years
Category
Clinical Guidelines
30
Countries
26
Pharmacy & Technologies
6
Women & Child Health
5
Capacity Building
1
Public Health
1
Key Resources
1
Toolboxes
COVID-19
38
AMR
28
HIV
10
Ebola
9
TB
9
Pharmacy
8
Rapid Response
7
Mental Health
4
Planetary Health
4
Refugee
3
NTDs
3
Zika
2
Disability
1
Natural Hazards
1
This manual addresses all the issues. It focus on the cycle of microbes, antibiotics, vaccination, AMR, infection prevention and control. It will support nurses on better action and also on communication towards their patients and families.

Improving Access to and Appropriate Use of Medicines for Mental Disorders

Corrado Barbui, Tarun Dua, Kavitha Kolappa et al. World Health Organization and Calouste Gulbenkian Foundation (2017) C_WHO
9 April 2020 WHO has published the guidance “Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected” This document is intended for clinicians taking care of hospitalized adult and paediatric patients with severe acute respiratory infection (SARI) whe... more
The objective of this document is to guide the preparation and implementation of national preparedness plans for the safety of substances of human origin during outbreaks of Zika virus infection, both in affected and non-affected areas.
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands). Monkeypox (MPX) does not spread easily between people. Human-to-human transmission occurs through close contact ... more
8 March 2022 A very large number of people from Ukraine are fleeing the country and entering the European Union (EU) countries bordering Ukraine (Hungary, Poland, Romania, Slovakia) and the EU-neighbourhood country of the Republic of Moldova. Those... more
A One Health Response. A Briefing Note
March 2022. This report on good practices to combat AMR focuses on activities across human, animal, and environmental health in European countries. The report provides a description of practices, how they were implemented, achievements, and why the ... more
Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program. Arlington, VA: Management Sciences for Health. Submitted to the United Nations Children’s Fund by JSI, Arl... more
This policy brief has been developed in response to the contemporary challenge of antibiotic resistance (‎ABR)‎. ABR poses a formidable threat to global health and sustainable development. It is now increasingly recognized that the systematic neglect of cultural factors is one of the biggest obs... more
How to address the global crisis in antibiotic research and development. The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we ... more
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation ... more
WHO and UNITAID in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Gr... more
Exciting new treatment approaches make the management of hepatitic C one of the most rapidly developing areas of medicine. The Flying Publisher short Guide to Hepatitis C is an up-to-date source of information for physicians, residents and advanced ... more
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen... more
This document focuses on the management of patients affected by gambiense HAT and constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa... more
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world. In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f... more